Clinical Trials Logo

Filter by:
NCT ID: NCT01673763 Completed - Clinical trials for Post-ERCP Acute Pancreatitis

Post-ERCP Pancreatitis Prevention by Stent Insertion

PEPSI
Start date: July 2010
Phase: N/A
Study type: Interventional

The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.

NCT ID: NCT01673399 Completed - Clinical trials for Implantation Failure

Oxytocin Antagonist in Patients With Repeated Failure of Implantation

Start date: February 2012
Phase: Phase 4
Study type: Interventional

In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.

NCT ID: NCT01673126 Completed - Clinical trials for Minimally Conscious State

Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness

tDCS in DOC
Start date: January 2010
Phase: Phase 2
Study type: Interventional

Previous studies showed that anodal transcranial direct current stimulation (tDCS) applied to the left dorsolateral prefrontal (DLPF) cortex transiently improves performance of memory and attention. Investigator assessed the effects of left DLPF-tDCS on Coma Recovery Scale-Revised (CRS-R) scores in severely brain damaged patients with disorders of consciousness in a double-blind sham-controlled experimental design.

NCT ID: NCT01672853 Completed - Clinical trials for Primary Sclerosing Cholangitis (PSC)

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Start date: March 4, 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether simtuzumab (GS-6624) is effective at preventing the progression of liver fibrosis in adults with primary sclerosing cholangitis (PSC).

NCT ID: NCT01671644 Completed - Infertility Clinical Trials

Eeva™ Pregnancy Investigational Clinical Study: A Postmarket Follow-Up Study

EPIC
Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of this postmarket study is to gather data to evaluate the impact of using Eeva with traditional morphology grading on clinical pregnancy rates.

NCT ID: NCT01671007 Completed - Stroke Clinical Trials

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Start date: August 22, 2012
Phase:
Study type: Observational

In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

NCT ID: NCT01669837 Completed - Inguinal Hernia Clinical Trials

An Efficiency/Safety Study of Surgical Tissue Glue to Treat Inguinal Hernias

Start date: May 2012
Phase:
Study type: Observational

Prospective, multicenter, observational registry to collect data of laparoscopic inguinal hernia repair using surgical tissue glue fixation. The objective is to determine the prevalence of chronic pain at 1 year.

NCT ID: NCT01669096 Completed - Tuberculosis Clinical Trials

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Start date: August 21, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and immunogenicity of two doses of the TB vaccine administered according to a 0, 1 month schedule. In, addition, blood samples collected at different time points after vaccination will be analysed to see when exactly genes are activated by the vaccine using an assay called mRNA expression profiling. The different methods for mRNA expression profiling using whole blood samples versus Peripheral Blood Mononuclear cell(s) (PBMCs), will also be compared.

NCT ID: NCT01668784 Completed - Clinical trials for Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Start date: October 9, 2012
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell renal cell carcinoma who have received prior anti-angiogenic therapy

NCT ID: NCT01668589 Completed - Clinical trials for Postmenopausal Osteoporosis

Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis

Start date: November 28, 2011
Phase: N/A
Study type: Observational

The main objective of this observational study was to describe medication-taking behavior of patients treated with denosumab for postmenopausal osteoporosis (PMO) at 12 and 24 months.